CLEAR CELL SARCOMA
Clinical trials for CLEAR CELL SARCOMA explained in plain language.
Never miss a new study
Get alerted when new CLEAR CELL SARCOMA trials appear
Sign up with your email to follow new studies for CLEAR CELL SARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Engineered immune cells take on childhood cancers in early trial
Disease control OngoingThis early-phase study tests a personalized cell therapy for children and young adults (up to age 26) with solid tumors that have come back or not responded to standard treatment. The therapy uses the patient's own immune cells, modified to recognize and attack a protein called B…
Matched conditions: CLEAR CELL SARCOMA
Phase: PHASE1 • Sponsor: Seattle Children's Hospital • Aim: Disease control
Last updated May 17, 2026 05:28 UTC
-
Engineered immune cells take aim at childhood cancers that Won't quit
Disease control OngoingThis early-stage study tests a treatment made from a patient's own immune cells, modified to recognize and attack solid tumors. It includes children and young adults (ages 1–30) whose cancer has returned or not responded to standard therapy. The goal is to find a safe dose and se…
Matched conditions: CLEAR CELL SARCOMA
Phase: PHASE1 • Sponsor: Seattle Children's Hospital • Aim: Disease control
Last updated May 17, 2026 05:09 UTC